LENZ Therapeutics, Inc.LENZNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-49.92%
↓ 174% below average
Average (5y)
67.21%
Historical baseline
Range
High:315.78%
Low:-49.92%
Volatility
544.2%
High variability
| Period | Value |
|---|---|
| 2024 | -49.92% |
| 2023 | 181.68% |
| 2022 | -44.31% |
| 2021 | 315.78% |
| 2020 | 0.00% |
| 2019 | 0.00% |